Amino Tadalafil / Research reference
Aminotadalafil, sometimes written amino tadalafil, is chemically distinct from tadalafil. It has its own molecular formula, registry identifiers and analytical literature. The publications highlighted here largely investigate identification in product samples and chemical interactions. They should not be presented as clinical trials of a medicine or as proof that the analogue shares tadalafil's benefits, absorption or safety.
Distinct analogue; primarily analytical evidenceA focused reference from the Disguised Alpha research network.
01 / The science
Start with the mechanism, identify the experimental model, and keep the limits in view.
PubChem records aminotadalafil as C₂₁H₁₈N₄O₄, while tadalafil is C₂₂H₁₉N₃O₄. This is a change in molecular identity, not merely a capsule, liquid or salt designation. Similar names cannot establish equal pharmacology or substitute for compound-specific evidence.
Read the primary source ↗Mass spectrometry and chromatography help distinguish aminotadalafil from related structures in complex samples. A successful identification method demonstrates analytical capability. It does not show therapeutic effectiveness, determine appropriate human exposure or establish the safety of a finished preparation.
Read the primary source ↗A Swissmedic-led investigation isolated an interaction product involving aminotadalafil and a furfural-related molecule. The authors proposed incompatibility with formulation ingredients as a possible origin. This illustrates why chemical identity, purity and stability are distinct questions and why each preparation needs its own evaluation.
Read the primary source ↗02 / Read with context
This educational identity profile does not verify the contents of any catalog product. It provides no dosing, administration or purchase guidance. Clinical claims for tadalafil are not assigned to aminotadalafil.
03 / Selected publications
Original records, study models and the limits that matter when interpreting a result.
The investigators used precise mass measurements and fragment assignments to characterize several synthetic analogues, including aminotadalafil. The work supports distinguishing related compounds instead of identifying them by broad similarity alone.
Reading limit: Structural characterization is not a human efficacy, pharmacokinetic or safety study.
Researchers identified a condensation product involving aminotadalafil and hydroxymethylfuraldehyde. They interpreted its presence as potentially resulting from an interaction with formulation ingredients.
Reading limit: This sample-specific observation does not define stability rates or prove that every aminotadalafil preparation forms the same product.
Tagami and colleagues developed a separation and identification method covering aminotadalafil alongside multiple related substances. The study shows the importance of resolving similar compounds within a mixture rather than treating a screening signal as a complete identity assessment.
Reading limit: The endpoints concern analytical separation and identification. No clinical effectiveness or treatment equivalence was tested.
A focused selection, not a systematic review. Studies concern the tested material and do not validate a supplier’s finished product.
Explore research & source notes →04 / Common questions
Quick answers for reading the science behind Amino Tadalafil.
The chemical name aminotadalafil refers to a separate molecular structure. A product using similar wording would need documentation to establish what it actually contains.
No. Those studies concern a different molecule. Evidence about an analogue must identify the actual compound tested, along with its formulation and study population.
No. A primary report identified aminotadalafil as an unapproved analogue in an adulterated supplement. Detection describes the sample; it does not confer approval or demonstrate benefit.
The cited analytical papers do not establish human pharmacokinetics, clinical effectiveness or a safety profile. Those questions require dedicated studies and cannot be answered by molecular resemblance.
Continue your research
Explore related compound references and primary sources in the Disguised Peptides research hub.
